23768 Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices 

ACHS–II. Data collection will be 

managed by the University of Alabama 

at Birmingham (UAB) and the Calhoun 

County Health Department (CCHD). 

A sample of 500 surviving ACHS 

cohort members with PCBs 

measurements will be enrolled in the 

ACHS–II. After informed consent, 

clinical assessments will be done. These 

will be for blood pressure, height, 

weight, hip, and body girth. A 

questionnaire will be answered by 

computer-assisted personal interviews 

(CAPIs). Questions will be asked for 

health, demographic, diet, and lifestyle 

factors. The self-reported responses will 

be compared to laboratory analytes. For 

these, blood samples will be drawn and 

analyzed. 

The ACHS–II will measure the same 

serum PCBs as in the first Anniston 

survey. In this way, changes in PCB 

levels can be studied. The ACHS–II will 

also include serum analytes for dioxins, 

furans, dioxin-like PCBs, and 

chlorinated pesticides. Additional 

analytes include blood measures of 

polybrominated biphenyls and heavy 

metals. Clinical biomarkers will include 

measures for thyroid, diabetes, lipids, 

and immune function. This will give a 

more complete profile of human 

exposures and health in Anniston, AL. 

The ATSDR is requesting a two-year 

approval for this information collection. 

The total annualized burden is 227 

hours. 

There are no costs to respondents 

other than their time. Each respondent 

will spend about 2 hours in the study. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs) 

Adults who took part in first Anniston Community Health Survey.Recruitment Telephone Script .......................

Survey for Refusals ........................................

Update Contact Information Form .................

333 

160 

250 

1 

1 

1 

2/60 

1/60 

1/60 

Medications Form ........................................... 250 1 3/60 

Blood Draw Form ........................................... 250 1 2/60 

Questionnaire ................................................. 250 1 45/60 

Ron A. Otten, 

Director, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–09363 Filed 4–19–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Developing Research Capacity 

to Assess Health Effects Associated with 

Volcanic Emissions and other 

Environmental Exposures, Funding 

Opportunity Announcement (FOA) 

EH13–002, Initial Review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned SEP: 

Time and Date: 1:00 p.m.–4:00 p.m., 

June 18, 2013 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters to be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Developing Research Capacity to 

Assess Health Effects Associated with 

Volcanic Emissions and other 

Environmental Exposures, FOA EH–13– 

002’’. 

Contact Person for More Information: 

J. Felix Rogers, Ph.D., M.P.H., Scientific 

Review Officer, CDC, 4770 Buford 

Highway, NE., Mailstop F63, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

4334. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign FEDERAL REGISTER

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2013–09403 Filed 4–19–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–10151] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Reinstatement with change of a 

previously approved collection; Title of 

Information Collection: Data Collection 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices 23769 

for Medicare Beneficiaries Receiving 

Implantable Cardioverter-Defibrillators 

for Primary Prevention of Sudden 

Cardiac Death; Use: CMS provides 

coverage for implantable cardioverterdefibrillators (ICDs) for secondary 

prevention of sudden cardiac death 

based on extensive evidence showing 

that use of ICDs among patients with a 

certain set of physiologic conditions are 

effective. Accordingly, CMS considers 

coverage for ICDs reasonable and 

necessary under Section 1862(a)(1)(A) of 

the Social Security Act. However, 

evidence for use of ICDs for primary 

prevention of sudden cardiac death is 

less compelling for certain patients. 

To encourage responsible and 

appropriate use of ICDs, CMS issued a 

‘‘Decision Memo for Implantable 

Defibrillators’’ on January 27, 2005, 

indicating that ICDs will be covered for 

primary prevention of sudden cardiac 

death if the beneficiary is enrolled in 

either an FDA-approved category B IDE 

clinical trial (42 CFR 405.201), a trial 

under the CMS Clinical Trial Policy 

(NCD Manual § 310.1) or a qualifying 

prospective data collection system 

(either a practical clinical trial or 

prospective systematic data collection, 

which is sometimes referred to as a 

registry). Form Number: CMS–10151 

(OMB#: 0938–0967); Frequency: 

Occasionally; Affected Public: Private 

Sector; Business or other for-profits, 

Not-for-profit institutions; Number of 

Respondents: 1,702; Total Annual 

Responses: 82; Total Annual Hours: 

139,356. (For policy questions regarding 

this collection contact JoAnna Baldwin 

at 410–786–7205. For all other issues 

call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by June 21, 2013: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: April 17, 2013. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2013–09413 Filed 4–19–13; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Numbers: 93.581, 93.587, 93.612] 

Notice of Final Issuance on the 

Adoption of Administration for Native 

Americans (ANA) Program Policies 

and Procedures 

AGENCY: Administration for Native 

Americans (ANA), ACF, HHS. 

ACTION: Issuance of Final Policy 

Directive. 

SUMMARY: The Administration for 

Native Americans (ANA) is issuing final 

interpretive rules, general statements of 

policy and rules of agency organization, 

procedure, or practice relating to the 

following Funding Opportunity 

Announcements (FOAs): Social and 

Economic Development Strategies 

(hereinafter referred to as SEDS), 

SEDS—Native Asset Building Initiative 

(hereinafter referred to as NABI), 

Sustainable Employment and Economic 

Development Strategies (hereinafter 

referred to as SEEDS), Native Language 

Preservation and Maintenance 

(hereinafter referred to as Language 

Preservation), Native Language 

Preservation and Maintenance—Esther 

Martinez Initiative (hereinafter referred 

to as Language—EMI), and 

Environmental Regulatory Enhancement 

(hereinafter referred to as ERE). This 

notice also provides information about 

how ANA will administer these 

programs. 

DATES: The policies noted in the original 

Notice of Public Comment (NOPC) are 

effective immediately upon publication. 

FOR FURTHER INFORMATION CONTACT: 

Carmelia Strickland, Director, Division 

of Program Operations, ANA (877) 922– 

9262. 

SUPPLEMENTARY INFORMATION: Section 

814 of the Native Americans Programs 

Act of 1974, as amended, requires ANA 

to provide notice of its proposed 

interpretive rules, general statements of 

policy, and rules of agency organization, 

procedure or practice. The proposed 

clarifications, modifications, and new 

text will appear in the six FY 2013 

FOAs: SEDS, NABI, SEEDS, Language 

Preservation, Language—EMI, and ERE. 

ANA published a NOPC in the Federal 

Register (78 FR 13062) on February 26, 

2013, with proposed policy and 

program clarifications, modifications, 

and activities for the fiscal year (FY) 

2013 FOAs. The public comment period 

was open for 30 days. 

For information on the changes ANA 

is making, please refer to the NOPC at 

the following link: https://www.federal

register.gov/articles/2013/02/26/2013-

04383/request-for-public-comment-onthe-proposed-adoption-ofadministration-for-native-americansprogram. 

ANA received one comment from a 

Native non-profit organization. ANA 

considered the comment received and 

provides responses, clarifications, and 

modifications in this final directive. The 

following paragraph summarizes the 

comment and our response: 

A. Comment and Response 

Comment: ANA received one 

comment in reference to ANA’s new 

administrative policy focused on 

conflict of interest standards that states 

that staff employed through an ANAfunded project cannot also serve as a 

member of the governing body for the 

applicant organization. Therefore, staff 

employed through an ANA-funded 

project cannot also serve as a member of 

the governing body for the applicant 

organization. During the award 

negotiation phase, ANA will ask the 

prospective recipient to modify project 

personnel if a proposed staff member is 

also a member of the applicant 

organization’s governing body. In 

addition, there should be a separation of 

duties from staff and the governing 

bodies within an organization to ensure 

the integrity of internal controls and to 

minimize disruptions in the continuity 

of operations. 

The commenter stated that this policy 

would have a negative impact on the 

commenter’s organization’s ability to 

implement a grant as it currently allows 

two teachers to serve as members of the 

school board, as required by their 

bylaws. If this policy were 

implemented, the applicant would not 

have the ability to modify project 

personnel to align with this policy due 

to the extreme shortage of certified 


tkelley on DSK3SPTVN1PROD with NOTICES